Skip to content

REGEN BIOPHARMA, INC.: filings

Every REGEN BIOPHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 59 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-17fiscal Q3 202632960001493152-26-038576
10-Q2026-05-14fiscal Q2 202632960001493152-26-022924
10-Q2026-02-13fiscal Q1 202632650001493152-26-006526
10-K2025-12-30fiscal FY 202532660001493152-25-029526
10-Q2025-08-11fiscal Q3 202529830001641172-25-022884
10-Q2025-05-28fiscal Q2 202531870001641172-25-012619
10-Q2025-05-16fiscal Q1 202531620001641172-25-011206
10-K2025-05-13fiscal FY 202433650001641172-25-009968
10-Q2024-08-13fiscal Q3 202429940001607062-24-000238
10-Q2024-04-24fiscal Q2 202425740001607062-24-000131
10-Q2024-01-19fiscal Q1 202430620001607062-24-000033
10-K2023-11-20fiscal FY 202331740001607062-23-000524
10-Q2023-07-25fiscal Q3 202325780001607062-23-000371
10-Q2023-04-18fiscal Q2 202325740001607062-23-000215
10-Q2023-01-19fiscal Q1 202326560001607062-23-000028
10-K2022-11-15fiscal FY 202227640001607062-22-000694
10-Q2022-07-22fiscal Q3 202225750001607062-22-000477
10-Q2022-04-21fiscal Q2 202223620001607062-22-000295
10-Q2022-01-20fiscal Q1 202224480001607062-22-000026
10-K2021-12-22fiscal FY 202126620001607062-21-000641
10-Q/A2021-12-22fiscal Q3 202126750001607062-21-000637
10-Q2021-08-27fiscal Q3 202125730001607062-21-000299
10-Q2021-08-18fiscal Q2 202125720001607062-21-000282
10-Q2021-08-13fiscal Q1 202125540001607062-21-000269
10-Q2021-08-05fiscal Q3 202026800001607062-21-000257
10-Q2021-08-05fiscal Q2 202025740001607062-21-000255
10-Q2021-08-05fiscal Q1 202025530001607062-21-000254
10-K2021-08-04fiscal FY 202026650001607062-21-000250
10-K2021-06-21fiscal FY 201928690001607062-21-000165
10-Q2019-10-24fiscal Q3 201927820001607062-19-000407
10-Q2019-08-29fiscal Q2 201927780001607062-19-000352
10-Q2019-02-12fiscal Q1 201925510001607062-19-000067
10-K2018-12-27fiscal FY 201827670001607062-18-000491
10-Q2018-08-06fiscal Q3 201825680001607062-18-000238
10-Q2018-05-14fiscal Q2 201823630001607062-18-000165
10-Q2018-02-06fiscal Q1 201823340001607062-18-000047
10-K2018-01-05fiscal FY 201726420001607062-18-000006
10-Q2017-08-07fiscal Q3 201725340001607062-17-000256
10-Q2017-05-05fiscal Q2 201724330001607062-17-000189
10-Q/A2017-04-28fiscal Q1 201613130001607062-17-000165
10-K/A2017-04-28fiscal FY 201522370001607062-17-000163
10-Q/A2017-04-28fiscal Q3 201522330001607062-17-000161
10-Q/A2017-04-28fiscal Q2 201519260001607062-17-000159
10-Q/A2017-03-30fiscal Q1 201613130001607062-17-000124
10-K/A2017-03-30fiscal FY 201522370001607062-17-000122
10-Q/A2017-03-30fiscal Q3 201522330001607062-17-000120
10-Q/A2017-03-30fiscal Q2 201519260001607062-17-000118
10-Q2017-01-27fiscal Q1 201724470001607062-17-000038
10-K2016-12-21fiscal FY 201624580001607062-16-001092
10-Q2016-08-01fiscal Q3 201622580001607062-16-000928
10-Q2016-04-29fiscal Q2 201622600001607062-16-000813
10-Q2016-01-28fiscal Q1 201624500001607062-16-000610
10-K2016-01-07fiscal FY 201521540001607062-16-000576
10-Q2015-07-29fiscal Q3 201522570001607062-15-000336
10-Q2015-05-07fiscal Q2 201518450001607062-15-000195
10-Q2015-02-04fiscal Q1 201519370001607062-15-000043
10-K2014-12-18fiscal FY 201419510001607062-14-000203
10-Q2014-08-07fiscal Q3 201419570001607062-14-000052
10-Q2014-05-05fiscal Q2 201419560001554795-14-000345

8 further filings tag fewer than eight published concepts and have no page.

Inspect the source

Entity
REGEN BIOPHARMA, INC. / CIK 0001589150
Captured
2026-09-20T09:23:48.532Z
SEC response SHA-256
0bbe246b6080c7701ba978807745a4ba9de62971ab4db32e8d3e2fa2c4f26a87

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001589150.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))